Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Unknown 2Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2CNS 1

Conditions

Pancreatic Neoplasms 2Ketosis 1Insulin Resistance 1Glioma 1Glioblastoma 1Diabetes Mellitus, Type 2 1Diabetes Mellitus 1Brain Neoplasms 1Astrocytoma 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2385Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1833Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1017Vincristine 964Cetuximab 945Trastuzumab 945Prednisone 942Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Hypoglycemic Agents × Clear all
NCT07272109 2025-12-15

PTCA199-16

Fudan University

Phase 3 Not yet recruiting
210 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT06100796 2023-10-25

NSCLC

Assiut University

Unknown
60 enrolled

Diabetes Mellitus

NCT02149459 2017-10-27

SMC 0712-13

Sheba Medical Center

Phase 1 Unknown
18 enrolled
CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Insulin Resistance, Ketosis

NCT02475499 2016-03-14

Incretin-based Drugs and Pancreatic Cancer

Canadian Network for Observational Drug Effect Studies, CNODES

Completed
886,172 enrolled
Gastrointestinal

Diabetes Mellitus, Type 2, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡